[Value of the ELISA IgG and IgM test in the diagnosis and post-therapeutic monitoring of kala-azar].
D000965:Antimony / Q000627:therapeutic use; D000981:Antiprotozoal Agents / Q000627:therapeutic use; D004797:Enzyme-Linked Immunosorbent Assay; D005455:Fluorescent Antibody Technique; D006801:Humans; D007124:Immunoenzyme Techniques; D007074:Immunoglobulin G / Q000032:analysis*; D007075:Immunoglobulin M / Q000032:analysis*; D007898:Leishmaniasis, Visceral / Q000188:drug therapy / Q000276:immunology*; D008536:Meglumine; D000077485:Meglumine Antimoniate; D009942:Organometallic Compounds; D012217:Rheumatoid Factor / Q000032:analysis
D000981:Antiprotozoal Agents; D007074:Immunoglobulin G; D007075:Immunoglobulin M; D009942:Organometallic Compounds; D008536:Meglumine; D000077485:Meglumine Antimoniate; D012217:Rheumatoid Factor; D000965:Antimony
Valeur du test ELISA IgG et IgM dans le diagnostic et la surveillance post-thérapeutique du kala-azar.